CRIS Current Research Information System

MURATORI, LUIGI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.180
AS - Asia 7.224
EU - Europa 5.283
SA - Sud America 432
AF - Africa 406
OC - Oceania 22
Totale 21.547
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.085
VN - Vietnam 2.115
CN - Cina 1.907
SG - Singapore 1.842
GB - Regno Unito 1.284
IT - Italia 934
DE - Germania 735
SE - Svezia 616
HK - Hong Kong 414
FR - Francia 349
IN - India 338
BR - Brasile 286
RU - Federazione Russa 273
UA - Ucraina 268
IE - Irlanda 176
NL - Olanda 147
JP - Giappone 138
KR - Corea 130
FI - Finlandia 108
ZA - Sudafrica 103
EE - Estonia 86
CI - Costa d'Avorio 78
TG - Togo 72
CH - Svizzera 71
SC - Seychelles 64
AR - Argentina 63
PH - Filippine 45
CA - Canada 43
BG - Bulgaria 42
AT - Austria 37
BD - Bangladesh 36
TR - Turchia 34
ID - Indonesia 33
TH - Thailandia 33
JO - Giordania 32
PL - Polonia 32
MX - Messico 30
EC - Ecuador 29
IQ - Iraq 27
BE - Belgio 22
NG - Nigeria 22
TW - Taiwan 17
PK - Pakistan 16
RO - Romania 16
SA - Arabia Saudita 15
AU - Australia 14
GR - Grecia 14
HR - Croazia 14
ES - Italia 13
MA - Marocco 13
CL - Cile 12
EG - Egitto 10
PY - Paraguay 10
TN - Tunisia 10
VE - Venezuela 10
MY - Malesia 9
KE - Kenya 8
LT - Lituania 8
CO - Colombia 7
DZ - Algeria 7
IR - Iran 7
NZ - Nuova Zelanda 7
PT - Portogallo 7
UY - Uruguay 6
UZ - Uzbekistan 6
CZ - Repubblica Ceca 5
SK - Slovacchia (Repubblica Slovacca) 5
AO - Angola 4
CR - Costa Rica 4
DO - Repubblica Dominicana 4
NP - Nepal 4
OM - Oman 4
PE - Perù 4
SN - Senegal 4
SY - Repubblica araba siriana 4
AL - Albania 3
BO - Bolivia 3
GH - Ghana 3
IL - Israele 3
JM - Giamaica 3
KZ - Kazakistan 3
LB - Libano 3
NO - Norvegia 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BY - Bielorussia 2
ET - Etiopia 2
FK - Isole Falkland (Malvinas) 2
LU - Lussemburgo 2
LV - Lettonia 2
MT - Malta 2
NI - Nicaragua 2
PA - Panama 2
AG - Antigua e Barbuda 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BZ - Belize 1
CG - Congo 1
CM - Camerun 1
CY - Cipro 1
Totale 21.528
Salva come PNG Salva come JPEG
Città #
Singapore 1.247
Southend 1.105
Fairfield 928
Ashburn 841
Dong Ket 564
Chandler 552
Seattle 439
Woodbridge 436
Houston 409
Santa Clara 390
Hong Kong 389
Ho Chi Minh City 384
Wilmington 376
San Jose 360
Hefei 330
Cambridge 325
Hanoi 317
Princeton 258
Ann Arbor 219
Beijing 208
Dublin 175
Boardman 172
Jacksonville 169
Bologna 132
Lauterbourg 130
Nanjing 129
Tokyo 116
Seoul 110
Padova 107
Westminster 105
Los Angeles 102
Berlin 100
Helsinki 93
Frankfurt am Main 88
Jinan 83
Abidjan 78
Lomé 72
Da Nang 70
Milan 68
Council Bluffs 67
Buffalo 59
New York 59
Shenyang 59
Haiphong 57
Bern 56
Saint Petersburg 55
Dallas 53
San Diego 48
Changsha 45
Redondo Beach 41
Rome 40
Sofia 40
Hebei 39
Guangzhou 38
Des Moines 37
Bremen 36
Mülheim 36
Shanghai 36
São Paulo 34
Tianjin 33
Amman 32
Bengaluru 32
Nanchang 32
Phoenix 32
Turin 31
Zhengzhou 28
Hangzhou 26
London 26
Nuremberg 23
Munich 22
Vienna 22
Brussels 21
Haikou 21
Hải Dương 21
Medford 21
Orem 21
Taiyuan 21
Abeokuta 20
Dearborn 20
Warsaw 20
Chicago 19
Ningbo 19
Bühl 18
Jakarta 18
Mahé 18
Norwalk 18
Can Tho 17
Falkenstein 17
Jiaxing 17
Taizhou 17
Verona 17
Falls Church 16
Ninh Bình 16
Toronto 16
Yubileyny 16
Biên Hòa 15
Chengdu 15
Moscow 15
San Francisco 15
Washington 15
Totale 13.970
Salva come PNG Salva come JPEG
Nome #
Paraneoplastic Anti-Tif1-gamma Autoantibody-positive Dermatomyositis as Clinical Presentation of Hepatocellular Carcinoma Recurrence 354
Anti-Saccharomyces cerevisiae and perinuclear anti-neutrophil antibodies in coeliac disease before and after gluten free diet. 297
A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis 272
COVID-19 and Immunological Dysregulation: Can Autoantibodies be Useful? 268
Antibodies to SS-A/Ro-52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis. 254
Type 1 autoimmune hepatitis: patterns of clinical presentation and differential diagnosis of the 'acute' type. 252
Clinical and serological profile of primary biliary cirrhosis in men. 239
Antinuclear antibodies in COVID 19 237
'True' antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both? 235
Antinuclear antibodies as ancillary markers in primary biliary cirrhosis. 235
Clinical features of type 1 autoimmune hepatitis in elderly Italian patients 233
Anti-nuclear antibodies giving the “multiple nuclear dots” (MND) or the “rim-like/membranous” (RL/M) patterns: diagnostic accuracy for primary biliary cirrhosis. 231
Autoimmune liver disease and concomitant extrahepatic autoimmune disease 227
Application of the 2010 American Association for the study of liver diseases criteria of remission to a cohort of Italian patients with autoimmune hepatitis. 224
A COMPLEX IMMUNOREGULATORY DEFICIENCY CHARACTERISES TYPE 1 AUTOIMMUNE HEPATITIS. 224
Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs 218
Clinical impact of non-organ-specific autoantibodies on the response to combined antiviral treatment in patients with hepatitis C 214
Serum antibody reactivity to human intracisternal A-type particle retrovirus proteins in systemic sclerosis patients 214
Anti-actin IgA antibodies in severe coeliac disease 214
SPECIFICITY OF ANTI-SP100 ANTIBODY FOR PRIMARY BILIARY CIRRHOSIS. 209
Multiple nuclear dots and rim-like/membranous IgG isotypes in primary biliary cirrhosis. 206
Antimitochondrial antibodies positive autoimmune hepatitis with acute onset 200
Acute icteric hepatitis induced by a short course of low-dose cyclophosphamide in a patient with lupus nephritis 198
Clinical Impact and behaviour of serum autoantibodies in adult liver transplantation 195
Features and Progression of Asymptomatic Autoimmune Hepatitis in Italy 194
Autoantibodies in Autoimmune Hepatitis 193
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score 193
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis 192
CLINICAL FEATURES OF PRIMARY BILIARY CIRRHOSIS IN YOUNG AND ELDERLY PATIENTS. 192
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 189
Antibodies to soluble liver antigen in patients with various liver diseases: A multicentre study 186
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 185
Diagnosis and therapy of autoimmune hepatitis. 184
Autoimmune liver disease 2007. 182
Type 1 and type 2 autoimmune hepatitis in adults share the same clinical phenotype 182
Antibodies to filamentous actin (F-actin) in type 1 autoimmune hepatitis. 182
Clinical and prognostic implications of acute onset of Autoimmune Hepatitis: An Italian multicentre study 179
Blood-Based Non-Invasive Tests of Hepatic Fibrosis in Autoimmune Hepatitis: Application among Selected Patients Leads to Higher Accuracy 178
Autoimmune hepatitis in Italy: the Bologna experience. 177
Clinical implications of antimitochondrial antibody seropositivity in autoimmune hepatitis: a multicentre study 176
PML nuclear body component Sp140 is a novel autoantigen in primary biliary cirrhosis. 175
Anti-saccharomyces cerevisiae antibodies (ASCA) in coeliac disease. 173
Antimitochondrial antibodies and other antibodies in primary biliary cirrhosis: diagnostic and prognostic value 172
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 172
Primary biliary cirrhosis specific anti-nuclear antibodies in patients from Spain. 171
ARFI elastography in patients with chronic autoimmune liver diseases: A preliminary study 171
Clinical features and effect of antiviral therapy on anti-liver/kidney microsomal antibody type 1 positive chronic hepatitis C. 171
Redistribution of regulatory T-cells across the evolving stages of chronic hepatitis C. 169
Antifilamentous Actin Antibodies by ELISA for the Diagnosis of Type 1 Autoimmune Hepatitis. 169
Clinical and serological profile of primary biliary cirrhosis in young and elderly patients. 168
Antitransglutaminase antibodies and giardiasis 167
The western immunoblotting pattern of anti-mitochondrial antibodies is independent of the clinical expression of primary biliary cirrhosis 167
Specific antinuclear reactivities in primary biliary cirrhosis 165
PML NUCLEAR BODY COMPONENT SP140 IS A NOVEL AUTOANTIGEN IN PRIMARY BILIARY CIRRHOSIS. 165
Anti-ribosomal P protein antibody: an autoreactivity devoid of prognostic value in patients with autoimmune hepatitis. 165
Immunoglobulin GM and KM allotypes and prevalence of anti-LKM1 autoantibodies in patients with hepatitis C virus infection. 160
INCREASED REGULATORY POTENTIAL AND IMBALANCE OF THE VDELTA1/VDELTA2 RATIO IN PATIENTS WITH DIFFERENT MANIFESTATIONS OF HEPATITIS C. 160
Celiac disease in autoimmune cholestatic liver disorders 159
The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndrome. 158
Autoimmune hepatitis/primary biliary cirrhosis overlap syndrome and associated extrahepatic autoimmune diseases. 157
DETECTION OF MND AND RL/M ANTI-NUCLEAR ANTIBODIES PATTERNS: A RELIABLE DIAGNOSTIC TOOL IN ANTI-MITOCHONDRIAL ANTIBODIES NEGATIVE PRIMARY BILIARY CIRRHOSIS. 157
Standardization of Autoantibody Testing in Autoimmune Hepatitis 157
Evidence of a genetic basis for the different geographic occurrences of liver/kidney microsomal antibody type 1 in hepatitis C. 156
Diagnostic approach to autoimmune hepatitis 155
Liver injury with drugs used for multiple sclerosis: A contemporary analysis of the FDA Adverse Event Reporting System 155
Hepatocellular carcinoma in viral and autoimmune liver diseases: Role of CD4+ CD25+ Foxp3+ regulatory T cells in the immune microenvironment 155
De novo autoimmune hepatitis in liver transplant: State-of-the-art review 154
Factors associated with response to therapy and outcome of patients with primary biliary cirrhosis with features of autoimmune hepatitis. 152
Multiple viral/self immunological cross-reactivity in liver kidney microsomal antibody positive hepatitis C virus infected patients is associated with the possession of HLA B51 150
Autoimmune liver disease serology in acute hepatitis E virus infection 149
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways 149
HCV and autoimmunity. 147
Acute liver injury and anorexia nervosa: A case report 145
Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis. 145
Diagnosis of primary biliary cholangitis in a "teen" male patient 145
Nuclear Envelope Protein Autoantibodies/Antilamin Autoantibodies (Chapter 26) 145
Hepatic steatosis in chronic hepatitis C: impact on response to anti-viral treatment with peg-interferon and ribavirin 144
Regulatory T cell defects in adult autoimmune hepatitis. 142
Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: a multicenter study of 664 patients and 1992 healthy controls. 141
Diagnostic and therapeutic implications of bile duct injury in autoimmune hepatitis. 141
Two of them do it better: Novel serum biomarkers improve autoimmune hepatitis diagnosis 140
Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-line Therapy for Patients With Autoimmune Hepatitis. 140
Pathway-based analysis of primary biliary cirrhosis genome-wide association studies 139
Autoantibodies in antimithocondrial antibodies negative primary biliary cholangitis. 139
Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis 138
Decompensated cirrhosis as presentation of LKM1/LC1 positive type 2 autoimmune hepatitis in adulthood. A rare clinical entity of difficult management 136
Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: The International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program 136
Serum Smooth Muscle Antibodies (SMA). 131
Hyperferritinemia and hypergammaglobulinemia predict the treatment response to standard therapy in autoimmune hepatitis. 131
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. 129
Genetic distinction between autoimmune hepatitis in Italy and North America 128
Fatigue and pruritus at onset identify a more aggressive subset of primary biliary cirrhosis 128
Anti-neutrophil cytoplasm antibodies (ANCA) in autoimmune diseases: A matter of laboratory technique and clinical setting 128
Diagnostic role of anti-dsDNA antibodies: do not forget autoimmune hepatitis 126
Acute-on-chronic liver failure: A complex clinical entity in patients with autoimmune hepatitis 126
Diagnostic difficulties, therapeutic strategies, and performance of scoring systems in patients with autoimmune hepatitis and concurrent hepatitis B/C 124
Coronavirus disease associated immune thrombocytopenia: Causation or correlation? 123
Identification of new autoantigens by protein array indicates a role for IL4 neutralization in Autoimmune Hepatitis. 122
Sex differences associated with primary biliary cirrhosis. 122
Current topics in autoimmune hepatitis. 122
Totale 17.540
Salva come PNG Salva come JPEG
Categoria #
all - tutte 63.329
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.329
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.036 0 0 0 0 0 0 0 0 0 124 90 822
2021/20222.463 189 59 175 208 204 119 76 161 102 163 581 426
2022/20232.403 333 331 127 309 130 175 96 127 376 95 184 120
2023/2024736 48 111 51 68 53 115 39 66 21 43 62 59
2024/20253.123 171 449 323 250 545 170 184 88 64 183 111 585
2025/20266.587 534 696 616 560 793 405 653 170 1.648 512 0 0
Totale 21.920